Literature DB >> 25559801

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

Dean A Shumway1, Daniel A Hamstra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559801     DOI： 10.1200/JCO.2014.59.4093

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.

Authors:  Robert Steven Gerhard; Dattatraya Patil; Yuan Liu; Kenneth Ogan; Mehrdad Alemozaffar; Ashesh B Jani; Omer N Kucuk; Viraj A Master; Theresa W Gillespie; Christopher P Filson
Journal:  Urol Oncol       Date:  2017-01-12       Impact factor: 3.498

2.  Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.

Authors:  Martine T E Puts; Schroder Sattar; Kara McWatters; Katherine Lee; Michael Kulik; Mary-Ellen MacDonald; Raymond Jang; Eitan Amir; Monika K Krzyzanowska; Natasha Leighl; Margaret Fitch; Anthony M Joshua; Padraig Warde; Ann E Tourangeau; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2016-11-09       Impact factor: 3.603

Review 3.  Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?

Authors:  Aurore Goineau; Bénédicte d'Aillières; Laure de Decker; Stéphane Supiot
Journal:  Front Oncol       Date:  2015-10-15       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.